WHO ICTRP trial
Study of a new drug combination for the treatment of Non Hodgkin’s Lymphoma
EUCTR2008-004177-17-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-004177-17-BE |
|---|---|
| Public title | Study of a new drug combination for the treatment of Non Hodgkin’s Lymphoma |
| Scientific title | A Randomized, Open Label Study of Ofatumumab and Bendamustine Combination Therapy Compared with Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin’s Lymphoma Unresponsive to Rituximab or a Rituximab-Containing Regimen During or Within Six Months of Treatment |
| Primary sponsor | GlaxoSmithKline Research and Development Limited |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Slovakia;Greece;Poland;Belgium;Austria;Germany;United Kingdom;Italy |
| Conditions | Indolent B-cell Non-Hodgkin’s Lymphoma MedDRA version: 18.0 Level: HLGT Classification code 10025320 Term: Lymphomas non-Hodgkin's B-cell System Organ Class: 10005329 - Blood and lymphatic system disorders ;Therapeutic area: Diseases [C]… |
| Interventions | Product Name: ofatumumab Product Code: ofatumumab Pharmaceutical Form: Solution for infusion INN or Proposed INN: Ofatumumab Current Sponsor code: GSK1841157 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal… |
| Registration date | Feb 22, 2010 |
| Target size | 346 |
| Secondary IDs | OMB110918 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: